Australia markets closed

Anhui Sunhere Pharmaceutical Excipients Co.,Ltd. (300452.SZ)

Shenzhen - Shenzhen Delayed price. Currency in CNY
Add to watchlist
12.65+0.03 (+0.24%)
At close: 03:04PM CST
Currency in CNY

Valuation measures4

Market cap (intra-day) 2.97B
Enterprise value 2.65B
Trailing P/E 18.33
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)3.56
Price/book (mrq)3.56
Enterprise value/revenue 3.23
Enterprise value/EBITDA 15.04

Trading information

Stock price history

Beta (5Y monthly) 0.25
52-week change 3-26.28%
S&P500 52-week change 327.79%
52-week high 319.78
52-week low 39.92
50-day moving average 313.26
200-day moving average 315.13

Share statistics

Avg vol (3-month) 33.02M
Avg vol (10-day) 34.92M
Shares outstanding 5234.44M
Implied shares outstanding 6234.44M
Float 8136.88M
% held by insiders 142.45%
% held by institutions 16.28%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 40.25
Forward annual dividend yield 41.98%
Trailing annual dividend rate 30.25
Trailing annual dividend yield 31.98%
5-year average dividend yield 41.44
Payout ratio 436.23%
Dividend date 3N/A
Ex-dividend date 417 May 2023
Last split factor 21.3:1
Last split date 326 May 2022

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2022
Most-recent quarter (mrq)30 Sept 2023

Profitability

Profit margin 19.47%
Operating margin (ttm)17.53%

Management effectiveness

Return on assets (ttm)7.56%
Return on equity (ttm)19.83%

Income statement

Revenue (ttm)819.69M
Revenue per share (ttm)3.55
Quarterly revenue growth (yoy)13.40%
Gross profit (ttm)N/A
EBITDA 189.49M
Net income avi to common (ttm)159.61M
Diluted EPS (ttm)0.69
Quarterly earnings growth (yoy)23.70%

Balance sheet

Total cash (mrq)612.23M
Total cash per share (mrq)2.61
Total debt (mrq)293.98M
Total debt/equity (mrq)32.65%
Current ratio (mrq)3.47
Book value per share (mrq)3.55

Cash flow statement

Operating cash flow (ttm)122.94M
Levered free cash flow (ttm)41.64M